Header Logo

Connection

MEENAKSHI HEGDE to Adenoviridae

Back to Details
This is a "connection" page, showing publications MEENAKSHI HEGDE has written about Adenoviridae.
MEENAKSHI HEGDE
Connection Strength
0.029
Adenoviridae
  1. HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol. 2017 Aug 01; 3(8):1094-1101.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.